Literature DB >> 29791908

A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.

Jenny van der Wijst1, Martin Konrad2, Sjoerd A J Verkaart1, Marcin Tkaczyk3, Femke Latta1, Janine Altmüller4, Holger Thiele4, Bodo Beck5, Karl Peter Schlingmann2, Jeroen H F de Baaij1.   

Abstract

Mutations in the KCNA1 gene encoding the voltage-gated potassium (K+) channel Kv1.1 have been linked to rare neurological syndromes, episodic ataxia type 1 (EA1) and myokymia. In 2009, a KCNA1 mutation was identified in a large family with autosomal dominant hypomagnesemia. Despite efforts in establishing a genotype-phenotype correlation for the wide variety of symptoms in EA1, little is known on the serum magnesium (Mg2+) levels in these patients. In the present study, we describe a new de novo KCNA1 mutation in a Polish patient with tetany and hypomagnesemia. Electrophysiological and biochemical analyses were performed to determine the pathogenicity of the mutation. A female patient presented with low serum Mg2+ levels, renal Mg2+ wasting, muscle cramps, and tetanic episodes. Whole exome sequencing identified a p.Leu328Val mutation in KCNA1 encoding the Kv1.1 K+ channel. Electrophysiological examinations demonstrated that the p.Leu328Val mutation caused a dominant-negative loss of function of the encoded Kv1.1 channel. Cell surface biotinylation showed normal plasma membrane expression. Taken together, this is the second report linking KCNA1 with hypomagnesemia, thereby emphasizing the need for further evaluation of the clinical phenotypes observed in patients carrying KCNA1 mutations.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Genetics; Hypomagnesemia; Magnesium; Patch clamp; Potassium channel

Mesh:

Substances:

Year:  2018        PMID: 29791908      PMCID: PMC6492638          DOI: 10.1159/000488954

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  26 in total

1.  Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.

Authors:  L H Eunson; R Rea; S M Zuberi; S Youroukos; C P Panayiotopoulos; R Liguori; P Avoni; R C McWilliam; J B Stephenson; M G Hanna; D M Kullmann; A Spauschus
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

2.  Episodic ataxia results from voltage-dependent potassium channels with altered functions.

Authors:  J P Adelman; C T Bond; M Pessia; J Maylie
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

3.  Electrophysiological characterization of rabbit distal convoluted tubule cell.

Authors:  K Yoshitomi; T Shimizu; J Taniguchi; M Imai
Journal:  Pflugers Arch       Date:  1989-08       Impact factor: 3.657

4.  Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.

Authors:  Enriqueta Tristán-Clavijo; Francisco G Scholl; Alfons Macaya; Gemma Iglesias; Ana M Rojas; Miguel Lucas; Antonio Castellano; Amalia Martinez-Mir
Journal:  Mov Disord       Date:  2016-08-01       Impact factor: 10.338

5.  Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.

Authors:  Jenny van der Wijst; Bob Glaudemans; Hanka Venselaar; Anil V Nair; Anna-Lena Forst; Joost G J Hoenderop; René J M Bindels
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

6.  Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment.

Authors:  Stephen B Long; Xiao Tao; Ernest B Campbell; Roderick MacKinnon
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

7.  Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.

Authors:  Steven J Shook; Hafsa Mamsa; Joanna C Jen; Robert W Baloh; Lan Zhou
Journal:  Muscle Nerve       Date:  2008-03       Impact factor: 3.217

8.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

9.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

Review 10.  New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

Authors:  Maria Cristina D'Adamo; Sonia Hasan; Luca Guglielmi; Ilenio Servettini; Marta Cenciarini; Luigi Catacuzzeno; Fabio Franciolini
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

View more
  9 in total

1.  Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.

Authors:  Rían W Manville; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2020-03-26       Impact factor: 4.030

Review 2.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

3.  Neuromuscular tetanic hyperexcitability syndrome associated to a heterozygous Kv1.1 N255D mutation with normal serum magnesium levels.

Authors:  Francesca Bianchi; Costanza Simoncini; Raffaella Brugnoni; Giulia Ricci; Gabriele Siciliano
Journal:  Acta Myol       Date:  2020-03-01

4.  Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.

Authors:  Li Liu; Yumei Chen; Qingyuan Zhang; Changzhong Li
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

5.  Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.

Authors:  Haiming Yuan; Huihua Yuan; Qingming Wang; Wanhua Ye; Ruixia Yao; Wanfang Xu; Yanhui Liu
Journal:  Mol Genet Genomic Med       Date:  2020-07-23       Impact factor: 2.183

6.  Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel.

Authors:  Paola Imbrici; Andrea Accogli; Rikard Blunck; Concetta Altamura; Michele Iacomino; Maria Cristina D'adamo; Anna Allegri; Marina Pedemonte; Noemi Brolatti; Stella Vari; Matteo Cataldi; Valeria Capra; Stefano Gustincich; Federico Zara; Jean-Francois Desaphy; Chiara Fiorillo
Journal:  Biomedicines       Date:  2021-01-14

7.  Hereditary kidney diseases associated with hypomagnesemia.

Authors:  Felix Claverie-Martin; Ana Perdomo-Ramirez; Victor Garcia-Nieto
Journal:  Kidney Res Clin Pract       Date:  2021-11-12

Review 8.  Potassium Channels as a Target for Cancer Therapy: Current Perspectives.

Authors:  Leandro Zúñiga; Angel Cayo; Wendy González; Cristian Vilos; Rafael Zúñiga
Journal:  Onco Targets Ther       Date:  2022-07-20       Impact factor: 4.345

Review 9.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

Authors:  Maria Cristina D'Adamo; Antonella Liantonio; Jean-Francois Rolland; Mauro Pessia; Paola Imbrici
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.